BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8955209)

  • 1. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
    Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines.
    Burg M; Martin U; Rheinheimer C; Köhl J; Bautsch W; Böttger EC; Klos A
    J Immunol; 1995 Nov; 155(9):4419-26. PubMed ID: 7594603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Fc gamma receptor expression and phagocytosis of a human monoblast cell line U937. Participation of cAMP and protein kinase C in the effects of IFN-gamma and phorbol ester.
    Nambu M; Morita M; Watanabe H; Uenoyama Y; Kim KM; Tanaka M; Iwai Y; Kimata H; Mayumi M; Mikawa H
    J Immunol; 1989 Dec; 143(12):4158-65. PubMed ID: 2556478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of the human IFN-gamma receptor expression in Raji and IM9 lymphoblastoid cells versus THP-1 monocytic cells by IFN-gamma and phorbol myristate acetate.
    Mao C; Merlin G; Aguet M
    J Immunol; 1990 Jun; 144(12):4688-96. PubMed ID: 2141042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation.
    Fukuoka Y; Ember JA; Hugli TE
    Biochem Biophys Res Commun; 1998 Jan; 242(3):663-8. PubMed ID: 9464274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
    Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
    Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intracellular calcium concentration and protein kinase C activation in IFN-gamma stimulation of U937 cells.
    Klein JB; Schepers TM; Dean WL; Sonnenfeld G; McLeish KR
    J Immunol; 1990 Jun; 144(11):4305-11. PubMed ID: 2140394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
    Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
    FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid.
    Zahn S; Zwirner J; Spengler HP; Götze O
    Eur J Immunol; 1997 Apr; 27(4):935-40. PubMed ID: 9130647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
    Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
    J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.
    Gasque P; Singhrao SK; Neal JW; Wang P; Sayah S; Fontaine M; Morgan BP
    J Immunol; 1998 Apr; 160(7):3543-54. PubMed ID: 9531317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
    Tardif M; Mery L; Brouchon L; Boulay F
    J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
    Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
    J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes.
    Wang C; Gerard NP; Nicholson-Weller A
    J Immunol; 1996 Jan; 156(2):786-92. PubMed ID: 8543834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.
    Legler DF; Loetscher M; Jones SA; Dahinden CA; Arock M; Moser B
    Eur J Immunol; 1996 Apr; 26(4):753-8. PubMed ID: 8625964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.